Upgrade to SI Premium - Free Trial

Dyne Therapeutics Inc. (DYN)

28.50 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/1/24)
- M&A (6/30/18 *Est)

Latest Headlines

Form 4 Dyne Therapeutics, Inc. For: Mar 25 Filed by: Cox John March 27, 2024 4:25 PM - SEC Filing Form 3 Dyne Therapeutics, Inc. For: Mar 25 Filed by: Cox John March 27, 2024 4:15 PM - SEC Filing Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer March 27, 2024 4:05 PM - StreetInsider Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium March 27, 2024 8:30 AM - StreetInsider Form 8-K Dyne Therapeutics, Inc. For: Mar 21 March 25, 2024 7:40 AM - SEC Filing Dyne Therapeutics (DYN) Announces CEO Transition March 25, 2024 7:30 AM - StreetInsider Dyne Therapeutics Announces CEO Transition March 25, 2024 7:30 AM - StreetInsider Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days March 13, 2024 7:30 AM - StreetInsider Form 4 Dyne Therapeutics, Inc. For: Mar 08 Filed by: HIGH SUSANNA GATTI March 13, 2024 6:05 AM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 08 Filed by: McNeill Jonathan March 13, 2024 6:05 AM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 11 Filed by: Farwell Wildon March 12, 2024 9:58 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 08 Filed by: Scalzo Richard William March 12, 2024 9:58 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 08 Filed by: Brumm Joshua T March 12, 2024 9:57 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 11 Filed by: Beskrovnaya Oxana March 12, 2024 9:43 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Farwell Wildon March 12, 2024 4:15 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: Brumm Joshua T March 11, 2024 9:58 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: Beskrovnaya Oxana March 11, 2024 9:57 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: HIGH SUSANNA GATTI March 11, 2024 9:57 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: Farwell Wildon March 11, 2024 9:53 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: McNeill Jonathan March 11, 2024 9:51 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 07 Filed by: Scalzo Richard William March 11, 2024 9:46 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Beskrovnaya Oxana March 11, 2024 5:37 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Farwell Wildon March 11, 2024 5:36 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan March 11, 2024 5:35 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T March 11, 2024 5:34 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: HIGH SUSANNA GATTI March 11, 2024 5:33 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William March 11, 2024 5:32 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William March 8, 2024 4:55 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan March 8, 2024 4:54 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: HIGH SUSANNA GATTI March 8, 2024 4:53 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T March 8, 2024 4:52 PM - SEC Filing Dyne Therapeutics (DYN) PT Raised to $31 at Chardan Capital Markets March 8, 2024 4:21 AM - StreetInsider Form 144 Dyne Therapeutics, Inc. Filed by: Farwell Wildon March 7, 2024 8:20 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Beskrovnaya Oxana March 7, 2024 8:19 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T March 7, 2024 8:18 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: HIGH SUSANNA GATTI March 7, 2024 8:18 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William March 7, 2024 8:17 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan March 7, 2024 8:17 PM - SEC Filing Dyne Therapeutics (DYN) PT Raised to $29 at Piper Sandler March 6, 2024 7:55 AM - StreetInsider Form 4 Dyne Therapeutics, Inc. For: Mar 01 Filed by: Rhodes Jason P March 5, 2024 5:08 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Mar 01 Filed by: Atlas Venture Opportunity Fund II, L.P. March 5, 2024 5:07 PM - SEC Filing Dyne Therapeutics (DYN) PT Raised to $41 at Stifel March 5, 2024 4:48 PM - StreetInsider Dyne Therapeutics (DYN) Files Mixed Shelf March 5, 2024 8:25 AM - StreetInsider Form S-3ASR Dyne Therapeutics, Inc. March 5, 2024 8:22 AM - SEC Filing Form 8-K Dyne Therapeutics, Inc. For: Mar 05 March 5, 2024 7:42 AM - SEC Filing Form S-8 Dyne Therapeutics, Inc. March 5, 2024 7:41 AM - SEC Filing Dyne Therapeutics (DYN) PT Raised to $47 at Oppenheimer March 5, 2024 7:41 AM - StreetInsider Form 10-K Dyne Therapeutics, Inc. For: Dec 31 March 5, 2024 7:36 AM - SEC Filing Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights March 5, 2024 7:30 AM - StreetInsider Form 4 Dyne Therapeutics, Inc. For: Feb 29 Filed by: Brumm Joshua T March 1, 2024 9:39 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Feb 29 Filed by: McNeill Jonathan March 1, 2024 9:38 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Feb 29 Filed by: Scalzo Richard William March 1, 2024 9:38 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T March 1, 2024 9:34 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William March 1, 2024 9:34 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan March 1, 2024 9:33 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P. March 1, 2024 5:25 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P. March 1, 2024 5:25 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T February 29, 2024 7:55 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William February 29, 2024 7:53 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan February 29, 2024 7:50 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Feb 26 Filed by: Rhodes Jason P February 28, 2024 7:16 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Feb 26 Filed by: Atlas Venture Opportunity Fund II, L.P. February 28, 2024 7:14 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Farwell Wildon February 28, 2024 5:37 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Feb 28 Filed by: Farwell Wildon February 28, 2024 5:36 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P. February 28, 2024 4:38 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P. February 27, 2024 5:24 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P. February 26, 2024 4:43 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Feb 21 Filed by: Rhodes Jason P February 23, 2024 7:00 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Feb 21 Filed by: Atlas Venture Opportunity Fund II, L.P. February 23, 2024 6:59 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P. February 23, 2024 5:29 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P. February 23, 2024 5:20 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P. February 23, 2024 5:20 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P. February 23, 2024 5:16 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Feb 15 Filed by: Rhodes Jason P February 20, 2024 6:37 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Feb 15 Filed by: Atlas Venture Associates XI, LLC February 20, 2024 6:36 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P. February 20, 2024 5:14 PM - SEC Filing H.C. Wainwright Starts Dyne Therapeutics (DYN) at Buy February 20, 2024 6:03 AM - StreetInsider Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P. February 15, 2024 5:29 PM - SEC Filing Form SC 13G/A Dyne Therapeutics, Inc. Filed by: CITADEL ADVISORS LLC February 14, 2024 4:58 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Feb 12 Filed by: Farwell Wildon February 14, 2024 4:28 PM - SEC Filing Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical February 14, 2024 4:16 PM - StreetInsider Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical February 14, 2024 4:15 PM - Globe NewsWire Form SC 13G/A Dyne Therapeutics, Inc. Filed by: Deep Track Capital, LP February 14, 2024 8:40 AM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Farwell Wildon February 12, 2024 5:40 PM - SEC Filing Form SC 13G/A Dyne Therapeutics, Inc. Filed by: MPM BIOVENTURES 2018, L.P. February 12, 2024 4:07 PM - SEC Filing Form SC 13G/A Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P. February 9, 2024 4:10 PM - SEC Filing Dyne Therapeutics to Present at February Investor Conferences February 1, 2024 7:30 AM - StreetInsider Form 4 Dyne Therapeutics, Inc. For: Jan 29 Filed by: Brumm Joshua T January 31, 2024 4:19 PM - SEC Filing Form SC 13G Dyne Therapeutics, Inc. Filed by: BlackRock Inc. January 29, 2024 3:27 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Jan 26 Filed by: Farwell Wildon January 26, 2024 7:50 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Jan 26 Filed by: McNeill Jonathan January 26, 2024 7:49 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Jan 26 Filed by: Scalzo Richard William January 26, 2024 7:48 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William January 26, 2024 7:47 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan January 26, 2024 7:47 PM - SEC Filing Dyne Therapeutics Inc. (DYN) Resumes Trading Following Halted, Now Up 36% January 26, 2024 2:54 PM - StreetInsider Avidity Biosciences (RNA) Spikes 15% Following Report Dyne Therapeutics Inc. (DYN) Received Takeover Interest January 26, 2024 2:38 PM - StreetInsider Dyne Therapeutics Inc. (DYN) Said To Weigh Options Amid Takeover Interest - Bloomberg January 26, 2024 2:28 PM - StreetInsider Form SC 13G Dyne Therapeutics, Inc. Filed by: Deep Track Capital, LP January 19, 2024 4:39 PM - SEC Filing Form SC 13G/A Dyne Therapeutics, Inc. Filed by: Deep Track Capital, LP January 19, 2024 9:09 AM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Jan 09 Filed by: Kersten Dirk January 11, 2024 4:32 PM - SEC Filing Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares January 11, 2024 4:05 PM - Globe NewsWire Dyne Therapeutics (DYN) PT Lowered to $27 at Piper Sandler January 8, 2024 7:17 AM - StreetInsider Form 424B5 Dyne Therapeutics, Inc. January 5, 2024 4:07 PM - SEC Filing Form 8-K Dyne Therapeutics, Inc. For: Jan 04 January 5, 2024 8:02 AM - SEC Filing Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference January 5, 2024 7:30 AM - StreetInsider Dyne Therapeutics Inc. (DYN) Prices 17.15M Share Offering at $17.50/sh January 5, 2024 5:44 AM - StreetInsider Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock January 4, 2024 10:46 PM - Globe NewsWire Form 4 Dyne Therapeutics, Inc. For: Jan 03 Filed by: Brumm Joshua T January 4, 2024 9:50 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Jan 03 Filed by: Beskrovnaya Oxana January 4, 2024 9:49 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Jan 02 Filed by: McNeill Jonathan January 4, 2024 9:48 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Jan 03 Filed by: Scalzo Richard William January 4, 2024 9:47 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T January 4, 2024 9:46 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Beskrovnaya Oxana January 4, 2024 9:46 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan January 4, 2024 9:46 PM - SEC Filing Form S-3MEF Dyne Therapeutics, Inc. January 4, 2024 9:20 PM - SEC Filing Dyne Therapeutics (DYN) Suspends ATM Offering January 4, 2024 5:17 PM - StreetInsider Form 8-K Dyne Therapeutics, Inc. For: Jan 04 January 4, 2024 5:13 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan January 3, 2024 8:15 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Scalzo Richard William January 3, 2024 8:14 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Brumm Joshua T January 3, 2024 8:14 PM - SEC Filing Form 144 Dyne Therapeutics, Inc. Filed by: Beskrovnaya Oxana January 3, 2024 8:13 PM - SEC Filing After-hours movers: MongoDB and Cal-Maine decline, Arena Group surges January 3, 2024 4:45 PM - StreetInsider Form 424B5 Dyne Therapeutics, Inc. January 3, 2024 4:37 PM - SEC Filing Dyne Therapeutics Inc. (DYN) Announces $175M Proposed Public Offering of Common Stock January 3, 2024 4:26 PM - StreetInsider Dyne Therapeutics Announces Proposed Public Offering of Common Stock January 3, 2024 4:25 PM - Globe NewsWire Dyne Therapeutics (DYN) PT Raised to $25 at JPMorgan January 3, 2024 3:59 PM - StreetInsider Dyne Therapeutics (DYN) PT Raised to $44 at Oppenheimer; 'Expectations Exceeded Across the Board' January 3, 2024 8:31 AM - StreetInsider Dyne Therapeutics (DYN) Climbs 100% Following Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial Data January 3, 2024 7:08 AM - StreetInsider Form 8-K Dyne Therapeutics, Inc. For: Jan 03 January 3, 2024 6:38 AM - SEC Filing Dyne Therapeutics (DYN) Reports Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial January 3, 2024 6:30 AM - StreetInsider Dyne Therapeutics Announces Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients Demonstrating Promise of the FORCEā„¢ Platform in Developing Therapeutic January 3, 2024 6:30 AM - StreetInsider Dyne Therapeutics to Host Virtual Event Tomorrow, January 3 at 8:00 AM ET, to Present Initial Clinical Data from ACHIEVE and DELIVER Trials January 2, 2024 4:05 PM - StreetInsider Form 144 Dyne Therapeutics, Inc. Filed by: McNeill Jonathan December 29, 2023 9:04 PM - SEC Filing Full Article List